Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 10 of 10 for “"tumor-draining lymph node"”.

  1. Integrated Multimodal Analysis: Evaluating the Impacts of Chemotherapy and Electroporation-Based Therapy on Lymphatic and Blood Microvasculature in Cancer

    The lymphatic and blood vascular systems are two important vessel networks that serve different roles in healthy states and in cancer. In breast cancer the most common cancer amongst women, mortality remains high despite increased treatment response due to metastatic spread, preferentially through …

    vt Repository record for Integrated Multimodal Analysis: Evaluating the Impacts of Chemotherapy and Electroporation-Based Therapy on Lymphatic and Blood Microvasculature in Cancer (opens in a new tab)

  2. The Role of Lymph Node Subcapsular Sinus Macrophages in Limiting Tumor Progression through a B-cell Response

    Cancer immunotherapy targeting antitumor T-cells is demonstrated to be promising in treating several types of cancers. Adoptive T-cell transfer and immune checkpoint inhibitors are among the most successful immunotherapies today. However, these therapies are not effective in all patients and they …

    calgary Repository record for The Role of Lymph Node Subcapsular Sinus Macrophages in Limiting Tumor Progression through a B-cell Response (opens in a new tab)

  3. The effect of transforming growth factor-beta on dendritic cell-based cancer vaccines

    The ability of dendritic cells (DCs) to stimulate tumor-specific T lymphocyte responses has made them prime candidates for cancer immunotherapy. Numerous studies have focused on enhancing the ability of DCs to stimulate the immune response. Commonly overlooked is the immunosuppressive milieu of the …

    arizona-thes Repository record for The effect of transforming growth factor-beta on dendritic cell-based cancer vaccines (opens in a new tab)

  4. Locoregional and systemic immunomodulation with intratumoral TCR agonism

    … cancer treatment however, success in solid tumors remains limited. With many solid tumors exhibiting heterogeneity and rapid growth, developing an easily accessible, off the shelf, potent T cell modulator that leverages the immune system’s intrinsic anti-tumor mechanisms to quickly to combat …

    gatech Repository record for Locoregional and systemic immunomodulation with intratumoral TCR agonism (opens in a new tab)

  5. Developing a personalized heterologous prime boost vaccination strategy for tumor therapy

    … is likely due to sub-optimal generation of anti-tumor CD8 T cells and insufficient tumor microenvironment (TME) modulation. In this study, a novel intravenous (IV) heterologous prime-boost vaccination strategy with a self-assembling neoantigen-peptide nanoparticle TLR-7/8 agonist (SNP) vaccine …

    oxford Repository record for Developing a personalized heterologous prime boost vaccination strategy for tumor therapy (opens in a new tab)

  6. Targeting the draining lymphatic network as a regulator of melanoma growth

    The lymphatic system is a complex network of lymph nodes and lymphatic vessels that performs crucial functions in human health and disease. In the context of cancers, including melanoma, the lymphatic system plays established roles in metastasis and immune suppression. However, recent work has …

    gatech Repository record for Targeting the draining lymphatic network as a regulator of melanoma growth (opens in a new tab)

  7. INTEGRATING HIGH THROUGHPUT DATA WITH SPATIAL SYSTEM PHARMACOLOGY MODEL TO PREDICT IMMUNOTHERAPY RESPONSE FOR TRIPLE NEGATIVE BREAST CANCER

    … between T cell recognition and killing of tumor cells that are counteracted through immunosuppressive pathways in the tumor microenvironment. Therefore, while measurements such as tumor mutational burden provide biomarkers to select patients for immunotherapy, they neither universally …

    jhu Repository record for INTEGRATING HIGH THROUGHPUT DATA WITH SPATIAL SYSTEM PHARMACOLOGY MODEL TO PREDICT IMMUNOTHERAPY RESPONSE FOR TRIPLE NEGATIVE BREAST CANCER (opens in a new tab)

  8. TUMOR-SPECIFIC DRAINING LYMPH NODE CD8 T CELLS ORCHESTRATE AN ANTI-TUMOR RESPONSE TO PD-1 IMMUNE CHECKPOINT BLOCKADE

    … PD-1 ICB was established to reinvigorate tumor T cells and reduce T cell exhaustion. However, the impact of PD-1 blockade on the induction and maintenance of tumor-relevant tdLN T cells and functional T cell memory in the context of surgical resection is not fully understood. We …

    cornell Repository record for TUMOR-SPECIFIC DRAINING LYMPH NODE CD8 T CELLS ORCHESTRATE AN ANTI-TUMOR RESPONSE TO PD-1 IMMUNE CHECKPOINT BLOCKADE (opens in a new tab)

  9. QUANTITATIVE SYSTEMS PHARMACOLOGY MODELS OF COMBINATION THERAPIES OF IMMUNE CHECKPOINT INHIBITORS AND AN EPIGENETIC MODULATOR IN BREAST CANCER

    … peripheral (all other organs and tissues), tumor-draining lymph node (TDLN), and tumor. The model comprises approximately 275 ordinary differential equations describing mechanistically the kinetics of molecular and cellular interactions and trafficking, based on experimental data. The model …

    jhu Repository record for QUANTITATIVE SYSTEMS PHARMACOLOGY MODELS OF COMBINATION THERAPIES OF IMMUNE CHECKPOINT INHIBITORS AND AN EPIGENETIC MODULATOR IN BREAST CANCER (opens in a new tab)

  10. Characterizing the immune landscape of tumor draining lymph nodes

    … to distant sites, rather than from the primary tumor itself.2 Regional spread of breast cancer to the tumor draining lymph nodes (TDLN) often precedes further dissemination to the rest of the body, and as such is an important prognostic tool during cancer diagnosis and staging.3 During tumor …

    bu Repository record for Characterizing the immune landscape of tumor draining lymph nodes (opens in a new tab)